logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

Feb 20, 2024•almost 2 years ago

Amount Raised

$9 Million

Round Type

series a

BedfordBiotechnology

Investors

Calculus CapitalMercia Ventures

Description

MIP Discovery has closed a £7 million GBP (~$9 million USD) Series A financing round, led by Mercia Ventures. The funding will be used to drive further commercialization of MIP Discovery’s novel synthetic affinity reagents within the cell and gene therapy space, along with supporting recruitment efforts to expand in-house cell and gene therapy expertise.

Company Information

Company

MIP Discovery

Location

Bedford, Bedfordshire, United Kingdom

About

MIP Discovery is the leading developer of non-biological affinity reagents, nanoMIPs, for diagnostics and healthcare applications. nanoMIP technology allows for the rapid development of polymer based affinity reagents targeted to small molecules, proteins and viruses, amongst other targets.

Related People

2 contacts

Sign in to view contact details

Sign in to view contact details

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers